CASTLEMAN TUMOR IN POSTERIOR MEDIASTINUM - LITERATURE REVIEW AND CASE REPORTS

Cung Văn Công1,
1 National Lung Hospital

Main Article Content

Abstract

Castleman Disease (CD) is a rare lymphoproliferative disorder typically characterized by the proliferation of a single or regional lymph node, usually occurring in the chest. Patients with CD may be asymptomatic or present with symptoms related to tumor impact on surrounding structures. It is difficult to reach a definitive diagnosis by imaging alone. Computed tomography and/or magnetic resonance imaging play a dominant role in supporting the diagnosis. Histological examination of lesions combined with immunohistochemical staining is the gold standard for disease identification. Complete surgical resection is the best primary treatment modality for CD, offering long-term survival and low recurrence rates. A few can be combined with monoclonal antibody therapy to be effective. In the chest, Castleman tumors are usually found in the anterior mediastinum and very rarely in the posterior mediastinum. We report one case of CD found in the posterior mediastinum, twice transthoracic biopsies gave incorrect results. The patient underwent surgery, histopathological results  and immunohistochemical staining confirmed a CD tumor. The discussion of the literature review will help readers gain a deeper understanding of this disease.

Article Details

References

1. Dispenzieri A, Fajgenbaum DC. Overview of Castleman disease. Blood. 2020 Apr 16;135(16):1353-1364. Doi 10.1182/blood.2019000931.PMID: 32106302
2. Wu D, Lim MS, Jaffe ES. Pathology of Castleman Disease. Hematol Oncol Clin North Am. 2018 Feb;32(1):37-52. doi: 10.1016/j.hoc.2017.09.004.PMID: 29157618
3. Iyoda A, Yusa T, Hiroshima K, et al. Castleman's disease in the posterior mediastinum: report of a case. Surg Today. 2000;30(5):473-6. doi: 10.1007/s005950050629.PMID: 10819491
4. Gupta V, Verma R, Malik D, et al. Castleman Disease Masquerading as the Posterior Mediastinal Mass on 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography. Indian J Nucl Med. 2019 Apr-Jun;34(2):171-172. doi: 10.4103/ijnm.IJNM_1_19.PMID: 31040538
5. Gündüz E, Özdemir N, Bakanay ŞM, Karakuş S. A Rare Lymphoproliferative Disease: Castleman Disease. Turk J Haematol. 2021 Dec 7;38(4):314-320. doi: 10.4274 /tjh.galenos.2021.2021.0440. Epub 2021 Nov 1.PMID: 34719151
6. Nakajima D, Aoyama A, Yamashina A, et al. Castleman disease in the posterior mediastinum showing atypical feature in computed tomography; report of a case. Kyobu Geka. 2005 Aug;58(9):845-7.PMID: 16104576
7. Moon WK, Im JG, Kim JS, et al. Mediastinal Castleman disease: CT findings. J Comput Assist Tomogr. 1994 Jan-Feb;18(1):43-6. doi: 10.1097/00004728-199401000-00009. PMID: 8282881
8. Erdogan A, Eser I, Ozbilim G. Posterior mediastinal localization of Castleman's disease: report of a case. Surg Today. 2004; 34(9):772-3. doi: 10.1007/s00595-004-2776-7.PMID: 15338352
9. Abramson JS. Diagnosis and Management of Castleman Disease. J Natl Compr Canc Netw. 2019 Nov;17(11.5):1417-1419. doi: 10.6004/ jnccn.2019.5037.PMID: 31766018